If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
TwoDumbtoSurvive,
but somehow, evidently we're both very wrong.
On the face of it not a great story, but could present an incredible opportunity.
https://www.theregister.com/2023/12/21/philips_exploding_mri/
The AIM is littered with worthless companies with great tech. I think people are more surprised this is still languishing in the sp regions of 2019 with virtually no sales post fda.
What we've got now is relief that positive news flow really might let LT holders replace belief with something a bit more tangible.
Fingers crossed this does become a catalyst for distribution.
dont forget that brasco are well acquainted with this market and how long it might take to get new product ducks in a row for sale. they had a punt presumably expecting a symbiotic relationship and as far as we know theyre still positive and a stakeholder.
thanks Deep.
i had a brief email exchange a few weeks ago too, and as you say have always found him honest and straight forward, which is comforting.
i think the manuals that have been referred to, in production currently, relied on the FDA 'labelling' for their content so couldn't have been completed ahead of time. I suppose that does make sense and explains why we might be at an appropriate 'stage' in business development.
its fair to say i was anticipating sales to follow the approval more quickly, i probably wasnt alone, but as ever good traction in the future will make the timing unimportant.
thanks again
thanks for sharing the link.
the interview is much more confidence inspiring than the SP action recently.
Christian says/ implies that all the research partners are converting their machines for commercial use, if anyone is putting together a list of questions for Monday would you mind adding confirmation of that point too please if you haven't already. if it's correct, again its a pretty serious confirmation of valuable the kit/ imagining service is.
if they're not all converting it would be interesting to know why not.
Or no news might be just due to no news. They don't really do RNs just for the sake of saying something. It would be great if the mother deal is about to land, but I reckon no news is more likely an indication of no news, rather than the incredible.
Hopefully I'm desperately wrong.
Nice to have a couple of bluebird days
Perhaps what's equally significant in this delivery is the lack of cardio toxicity. So, in my ignorance, that says to me if the anti cancer drug being delivered is having any beneficial effect, the patient can keep on getting treatment far beyond what would currently be possible.
A bigger dose hopefully means you reach a better place in a less time. And understanding the max helps avoid unknown side effects.